Friday 6 November 2026
Export ALB’s income statement to Excel — free account
Albemarle Corporation
ALB Basic Materials Specialty Chemicals
Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024.
- Revenue
- +18.8%
- EPS
- +225.6%
- Free cash flow
- +708.4%
- Total debt
- −48.1%
Quarter to September 2026, against a year earlier
98.44
3.47
+3.65%
Follow ALB
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
24.26 | 281.31 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.03 | 2.70 | 3.85 | 3.24 | |
P/FCF ratio |
9.24 | 11.79 | 34.78 | 22.95 | |
P/Operating CF |
17.58 | 22.43 | 61.11 | 42.84 | |
P/B ratio |
1.45 | 1.92 | 2.69 | 2.21 | |
Price to Tangible BV |
1.81 | 2.41 | 3.43 | 2.85 | |
EV/Sales |
2.03 | 2.74 | 3.99 | 3.54 | |
EV/EBITDA |
9.91 | 15.05 | 32.16 | 38.54 | |
EV/Operating CF |
6.95 | 8.98 | 20.30 | 14.21 | |
EV/FCF |
9.26 | 11.97 | 36.09 | 25.12 | |
Quick Ratio |
1.44 | 1.25 | 1.11 | 1.29 | |
Current Ratio |
2.34 | 2.09 | 2.07 | 2.23 | |
Net Debt/EBITDA |
0.11 | 0.40 | 2.02 | (29.35) | |
Debt/Assets |
11.70% | 11.80% | 12.43% | 19.50% | |
Debt/Equity |
0.17 | 0.18 | 0.19 | 0.33 | |
Asset Turnover |
0.37 | 0.36 | 0.34 | 0.31 | |
Operating CF/Net income |
0.00 | 1.62 | 1.25 | (0.85) | |
Capex/Depreciation |
0.00 | (0.46) | (0.63) | (0.91) | |
Interest Coverage |
5.33 | 14.65 | 7.05 | (3.76) | |
Research and Development Expense of Revenue |
0.53% | 0.21% | 0.64% | 0.85% | |
Selling, General and Administrative Expense of Revenue |
8.78% | 7.25% | 9.62% | 10.89% | |
Intangible Assets out of Total Assets |
0.10 | 0.11 | 0.11 | 0.10 | |
Share Based Compensation of Revenue |
0.62% | 0.39% | 0.55% | 0.86% | |
Graham Net Nets |
(0.08) | (0.09) | (0.08) | (0.16) | |
Graham Number |
84.48 | 27.56 | 0.00 | 0.00 | |
Earnings Yield |
4.12% | 0.36% | (1.89%) | (4.07%) | |
Free Cash Flow Yield |
10.83% | 8.48% | 2.87% | 4.36% | |
Revenue per Share |
13.16 | 14.78 | 12.12 | 12.14 | |
Operating CF per Share |
0.00 | 6.02 | 2.94 | 3.30 | |
Capex per Share |
0.00 | (0.61) | (0.84) | (1.26) | |
Free Cash Flow per Share |
0.00 | 5.41 | 2.10 | 2.04 | |
Cash per Share |
15.64 | 13.83 | 9.25 | 13.75 | |
Shareholders Equity per Share |
91.69 | 89.30 | 85.77 | 83.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
91.69 | 89.30 | 85.77 | 83.13 | |
Free Cash Flow |
— | 638.27 | 247.57 | 240.26 | |
Working Capital |
2,426.71 | 2,053.10 | 1,683.25 | 2,210.10 | |
Capital Expenditures |
— | (71.73) | (98.68) | (148.22) | |
Net Current Asset Value |
(1,030.52) | (1,427.04) | (1,772.28) | (2,584.61) | |
EV/EBIT |
20.28 | 64.16 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.04 | 0.07 | 0.10 | |
Price to Operating Income |
20.22 | 63.19 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
796.31 | 803.71 | 733.67 | 839.60 | |
Average Payables |
— | 987.22 | 925.87 | 928.71 | |
Average Inventory |
1,462.61 | 1,512.74 | 1,501.66 | 1,340.90 | |
Average Assets |
16,615.80 | 16,598.51 | 16,069.42 | 16,491.93 | |
Average Common Equity |
8,309.44 | 8,281.31 | 7,956.12 | 7,755.47 |
Columns are period end dates · fundamentals updated 4 Nov 2026